Clinicopathologic predictors of renal outcomes in light chain cast nephropathy: a multicenter retrospective study.

ABSTRACT: Light chain cast nephropathy (LCCN) in multiple myeloma often leads to severe and poorly reversible acute kidney injury. Severe renal impairment influences the allocation of chemotherapy and its tolerability; it also affects patient survival. Whether renal biopsy findings add to the clinical assessment in predicting renal and patient outcomes in LCCN is uncertain. We retrospectively reviewed clinical presentation, chemotherapy regimens, hematologic response, and renal and patient outcomes in 178 patients with biopsy-proven LCCN from 10 centers in Europe and North America. A detailed pathology review, including assessment of the extent of cast formation, was performed to study correlations with initial presentation and outcomes. Patients presented with a mean estimated glomerular filtration

SUBMITTER: Royal V 

PROVIDER: S-EPMC7243151 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature